India’s food regulator said on Friday (Sep 18) it had found a Nestle baby food sample to be substandard and was pursuing legal action against the Swiss company in one of its biggest growth markets.
Nestle said its products are “fully compliant with all the applicable regulations” and that it will continue to work closely with the regulator, without specifically commenting on the finding of a substandard sample.The scrutiny is the latest in a crackdown on India’s US$100 billion (S$127 billion) food industry which has included surprise factory visits and product testing.
Officials found a sample of Nestle “follow-up formula”, which is a milk product for infants, was “substandard with respect to biotin”, the Food Safety and Standards Authority of India (FSSAI) said.
The regulator specifies a standardised reference range for biotin, more commonly known as vitamin B7, in baby food.
“A reanalysis” of the sample found it was “non-conforming” with respect to prescribed biotin requirements under Indian laws, the regulator said in a social media post.
The FSSAI did not say whether it would order a recall of the product.
Nestle, whose shares in India fell almost 3 per cent following news of the action, counts India as a key growth market.
Milk and nutrition products, including infant formulas and baby foods, were Nestle India’s biggest revenue category in the year ending March 2026, generating a third of its product sales worth US$2.4 billion.
The FSSAI said it has also filed cases over two other Nestle baby food products, NAN Excella Pro Stage 1, and Lactogen Pro 1, for making misleading claims in breach of regulations.
“Three separate adjudication cases have been filed against Nestle,” the FSSAI said.
In response to the notice, Nestle India said it has again submitted its detailed response to the authorities regarding statements appearing on the label, “which are factual in nature, and supported by scientific literature”.
Reuters
